Resolution of Mild Ganciclovir-Resistant Cytomegalovirus Disease with Reduced-Dose Cidofovir and CMV-Hyperimmune Globulin
Ganciclovir-resistant cytomegalovirus (CMV) is associated with significant morbidity in solid organ transplant recipients. Management of ganciclovir-resistant CMV may be complicated by nephrotoxicity which is commonly observed with recommended therapies and/or rejection induced by “indirect” viral e...
Saved in:
Main Authors: | Samir J. Patel, Samantha A. Kuten, Richard J. Knight, Dana M. Hong, A. Osama Gaber |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Journal of Transplantation |
Online Access: | http://dx.doi.org/10.1155/2014/342319 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of Cytomegalovirus Infection with Cidofovir and CMV Immune Globulin in a Lung Transplant Recipient
by: Heinrike Wilkens, et al.
Published: (2016-01-01) -
Use of Ganciclovir in the Treatment of Acquired Cytomegalovirus Disease in a Preterm Infant
by: H Amin, et al.
Published: (1990-01-01) -
Incidence of ophthalmic manifestations in congenital cytomegalovirus (CMV)
by: Jennifer L. Rossen, et al.
Published: (2025-01-01) -
Method of obtaining and storing hyperimmune anthrax serum
by: S. V. Ivanova, et al.
Published: (2023-09-01) -
The mRNA-1647 vaccine: A promising step toward the prevention of cytomegalovirus infection (CMV)
by: Adewunmi Akingbola, et al.
Published: (2025-12-01)